BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE/DEXAMETHASONE IN NEWLY DIAGNOSED INTERMEDIATE-FIT AND FRAIL MULTIPLE MYELOMA: LONG-TERM EFFICACY AND SAFETY FROM THE PHASE 1/2 BELARD CLINICAL TRIAL

2026-04-01

0

PRE

AI

T

Terpos, E.

G

Gavriatopoulou, M.

S

Stathopoulos, I. N.

M

Malandrakis, P.

K

Kanellias, N.

M

Migkou, M.

T

Theodorakakou, F.

S

Solia, E.

P

Papaiakovou, E. E.

K

Kastritis, E.

D

Dimopoulos, M. A.

DOI：

Original request for help

Save

Abstract

En